Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-000744
Filing Date
2026-01-05
Accepted
2026-01-05 07:20:17
Documents
3
Period of Report
2026-01-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0270504-6k_newcelx.htm 6-K 11179
2 PRESS RELEASE TITLED: "NEWCELX APPOINTS DR. JULIEN BOISDRON, A SWISS BIG PHARMA ea027050401ex99-1_newcelx.htm EX-99.1 10991
3 GRAPHIC ex99-1_001.jpg GRAPHIC 133336
  Complete submission text file 0001213900-26-000744.txt   207130
Mailing Address THE CIRCLE 6 8058 ZURICH Switzerland
Business Address THE CIRCLE 6 8058 ZURICH Switzerland 41-41-618-80-00
NewcelX Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 26503891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)